As research into neurological diseases advances, fluid biomarkers derived from blood, cerebrospinal fluid, saliva, urine, and exosomes are opening new avenues for discovery and development. From neurofilaments and phosphorylated tau to glial fibrillary acidic protein, these biomarkers enable earlier disease detection and precise monitoring of therapeutic response, helping to accelerate clinical research. In this webinar, Yoav Noam, John Canfield, and John Allinson will discuss strategies to generate robust and reproducible biomarker data and the analytical considerations that support successful clinical studies.
Topics to be covered
- An automated immunoassay platform that improves assay sensitivity, dynamic range, and transferability for fluid biomarker measurement
- Analytical and reproducibility characterization of fluid biomarker immunoassays
- Importance of understanding assay performance and the requirement of in-study parallelism
- Benefits of leveraging industry partners to expedite study success
Tuesday, June 17th, 2025 | 11:00 AM - 12:30 PM Eastern Time
This webinar will be available to view live and on demand.
Speakers
Yoav Noam, PhD
Senior Manager, Research and Development
Bio-Techne
John Canfield, PhD
Associate Director, Laboratory Sciences
Immunologix Laboratories
John Allinson
Vice President, Biomarker Sciences
Immunologix Laboratories
